Buyer & Capital Landscape

FAQs

Who is buying psychiatry practices?

Two broad groups acquire psychiatry practices: strategic buyers (larger behavioral health operators expanding their footprint) and private-equity-backed platforms (investors building a larger company by combining practices). Each values different things and offers different terms, so identifying the buyer type early matters.

A strategic buyer is an operating company that integrates your practice into its own, often valuing fit and synergies. A financial (PE) buyer acquires to grow and eventually resell the combined business, often valuing scalability and your willingness to roll equity. Their priorities — and your role afterward — differ accordingly.

A roll-up is a strategy where an investor acquires a first “platform” practice, then adds smaller “add-on” practices to build scale. Early platform sellers and later add-on sellers experience very different deals — in valuation, structure, and how much independence remains.

Neither inherently. PE can bring capital, infrastructure, and a second bite at growth through rollover equity, but it also brings performance pressure and a future resale. Whether a PE buyer is right depends on your goals for cash, control, staff, and patient care — which is why fit matters as much as price.

Active buyers track the market constantly and often approach owners directly with unsolicited interest. Responding to a single unsolicited offer without testing the market is how sellers leave value on the table — competition among qualified buyers is what establishes a fair price.